The study itself says its primary end-point was negative. For a discussion, see http://www.sciencebasedmedicine.org/rituximab-for-chronic-fatigue-syndrome-jumpi

The study itself says its primary end-point was negative. For a discussion, see http://www.sciencebasedmedicine.org/rituximab-for-chronic-fatigue-syndrome-jumping-the-g/ http://www.sciencebasedmedicine.org/rituximab-for-chronic-fa...